CGON
CG Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$60.82
−4.18%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 100.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.24x
- Price / sales
- 865.55x
- Price / cash flow
- -30.21x
Enterprise value
- Enterprise value
- $4.4B
- EV / sales
- 701.86x
- EV / EBITDA
- -19.74x
- EV / EBIT
- -17.30x
- Market cap
- $5.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026